Spinal Cord Stimulation for Parkinsonism

ConditionParkinsonism
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-80
SponsorRuijin Hospital

About this trial

Spinal Cord Stimulation (SCS) is a newly emerged neuromodulation technique in recent years. It is now a mature technique in the treatment of chronic pain and is generally accepted by patients because of its non-destructive and reversible nature, few complications, no side effects, and avoidance of unnecessary surgical procedures. Combining the results of previous studies and the group's previous research, this study first proposes an innovative treatment protocol for PDS with SCS. We intend to conduct a prospective single-center open clinical trial to evaluate the improvement of orthostatic hypotension, urinary retention, sleep disturbance, dysarthria, and dysphagia in Parkinsonism (PDS) patients before and after SCS treatment, and shed new light on the treatment for PDS.

Eligibility criteria

Qualifiers

Diagnosed with parkinsonism according to MDS clinical diagnostic criteria for Parkinson's disease

Aged between 50 and 80 years

Able and willing to follow instruction of the researcher

No other conditions that the researchers consider inappropriate for inclusion

Disqualifiers

Severe depression (HAMD-17 above 17 as moderate to severe) or anxiety

Pregnancy

History of alcoholism

Non-neurological disease-related symptoms that prevent patients from participation in the study

Trial design

Treatments tested in this trial

  • Spinal cord stimulation

Treatment groups

50 Participants
are divided into 1 treatment group

Sponsors and collaborators